Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lexaria Corp (LXRP)

Lexaria Corp (LXRP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment

NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Hypertension: The Silent Killer Making...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.77 (+1.64%)
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Throw Hat into Hypertension Ring with Proprietary Drug-Delivery System

NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.77 (+1.64%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hypertension Innovation

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.77 (+1.64%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hypertension Treatment

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.77 (+1.64%)
Proactive North America headlines including Lexaria Bioscience, LeanLife Health, Planet 13 Holdings and Fidelity Minerals

New York, April 22, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

TOMDF : 0.0001 (-50.00%)
LUKEF : 0.0061 (+90.63%)
CPKF : 17.5250 (-1.54%)
WMG : 32.82 (-1.50%)
FMN : 11.07 (+0.04%)
SAIDF : 0.0500 (+25.00%)
SFET : 2.86 (+2.14%)
BLGO : 0.3485 (+2.68%)
GMBL : 0.8618 (+3.69%)
VEGA.CN : 0.0350 (+16.67%)
PLTXF : 0.0226 (-5.83%)
SWISF : 0.0435 (-10.49%)
Proactive news headlines including Lexaria Bioscience, ImagineAR, Blackrock Gold, Tetra Bio-Pharma and District Metals Corp

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

LXX.CN : 8.400 (-1.18%)
LXRP : 0.2249 (-10.68%)
IP.CN : 0.0400 (unch)
IPNFF : 0.0300 (+17.65%)
BRC : 59.68 (+0.17%)
TBPMF : 0.0002 (-77.78%)
MTRX : 13.20 (-1.27%)
RACMF : 1.2400 (-0.80%)
MKVNF : 0.1130 (+115.65%)
AREC : 1.5200 (+4.83%)
REX : 56.67 (+29.03%)
CYRTF : 0.8501 (+0.16%)
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering

KELOWNA, BC / ACCESSWIRE / January 12, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company") today announced that its common stock and warrants will begin trading on the...

LXRP : 0.2249 (-10.68%)
LEXX : 3.77 (+1.64%)
LEXXW : 1.6600 (+12.49%)
LXX.CN : 8.400 (-1.18%)
Lexaria Announces Effective Date for Reverse Stock Split

KELOWNA, BC / ACCESSWIRE / January 8, 2021 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it intends...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) Featured in Virtual Coverage of the LD Micro Main Event

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH

Remdesivir is one of several drugs to be evaluated KELOWNA, BC / ACCESSWIRE / December 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)

Barchart Exclusives

This Bausch Health Companies Unusually Active Option Is a No-Brainer
Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar